生物等效性
PLGA公司
生化工程
新产品开发
计算机科学
食品药品监督管理局
风险分析(工程)
药物开发
药品
纳米技术
医学
药理学
业务
材料科学
工程类
药代动力学
营销
纳米颗粒
作者
Omkara Swami Muddineti,Abdelwahab Omri
标识
DOI:10.1080/17425247.2022.2075845
摘要
The development of PLGA-based long-acting injectables is promising and challenging when considering the numerous interrelated delivery-related factors. Achieving a successful formulation requires a thorough understanding of the critical interactions between polymer/drug properties, release profiles over time, up-to-date knowledge on regulatory guidance, and elucidation of the impact of multiple in vivo conditions to methodically evaluate the eventual clinical efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI